Lu, Y.; Xu, M.; Chen, X.; Xu, H.; Sun, N.; Weisgerber, K.E.; Bai, R.-Y.
Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation. Cancers 2025, 17, 3788.
https://doi.org/10.3390/cancers17233788
AMA Style
Lu Y, Xu M, Chen X, Xu H, Sun N, Weisgerber KE, Bai R-Y.
Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation. Cancers. 2025; 17(23):3788.
https://doi.org/10.3390/cancers17233788
Chicago/Turabian Style
Lu, Yuqing, Manzhu Xu, Xiaojun Chen, Huazhen Xu, Nihao Sun, Karis E. Weisgerber, and Ren-Yuan Bai.
2025. "Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation" Cancers 17, no. 23: 3788.
https://doi.org/10.3390/cancers17233788
APA Style
Lu, Y., Xu, M., Chen, X., Xu, H., Sun, N., Weisgerber, K. E., & Bai, R.-Y.
(2025). Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation. Cancers, 17(23), 3788.
https://doi.org/10.3390/cancers17233788